Plain-English translation of NCT00061568 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
United States
Phase
Safety & dosing / Early efficacy
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Enrollment target
~130 participants
Started
July 2004
Primary completion
January 2023
Age range
2 Years – 80 Years
Last updated on clinicaltrials.gov in September 2026.